350 related articles for article (PubMed ID: 29106062)
1. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
Chen Y; Sun L; Guo D; Wu Z; Chen W
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
[TBL] [Abstract][Full Text] [Related]
2. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
4. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
Shi WB; Le VM; Gu CH; Zheng YH; Lang MD; Lu YH; Liu JW
J Pharm Sci; 2014 Apr; 103(4):1064-74. PubMed ID: 24523221
[TBL] [Abstract][Full Text] [Related]
5. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
[TBL] [Abstract][Full Text] [Related]
6. Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes.
Chen Z; Zhang T; Wu B; Zhang X
Int J Nanomedicine; 2016; 11():991-1002. PubMed ID: 27042054
[TBL] [Abstract][Full Text] [Related]
7. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF.
Şalva E; Turan SÖ; Eren F; Akbuğa J
Int J Pharm; 2015 Jan; 478(1):147-154. PubMed ID: 25445537
[TBL] [Abstract][Full Text] [Related]
8. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression.
Hajizadeh F; Moghadaszadeh Ardebili S; Baghi Moornani M; Masjedi A; Atyabi F; Kiani M; Namdar A; Karpisheh V; Izadi S; Baradaran B; Azizi G; Ghalamfarsa G; Sabz G; Yousefi M; Jadidi-Niaragh F
Eur J Pharmacol; 2020 Sep; 882():173235. PubMed ID: 32574672
[TBL] [Abstract][Full Text] [Related]
9. Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression.
Izadi S; Moslehi A; Kheiry H; Karoon Kiani F; Ahmadi A; Masjedi A; Ghani S; Rafiee B; Karpisheh V; Hajizadeh F; Atyabi F; Assali A; Mirzazadeh Tekie FS; Namdar A; Ghalamfarsa G; Sojoodi M; Jadidi-Niaragh F
Pharm Res; 2020 Sep; 37(10):196. PubMed ID: 32944844
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a.
Zhao Q; Li Y; Tan BB; Fan LQ; Yang PG; Tian Y
PLoS One; 2015; 10(8):e0132746. PubMed ID: 26292288
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of Drug Sensitivity by Knockdown of HIF-1α in Gastric Carcinoma Cells.
Zhao Q; Tan BB; Li Y; Fan LQ; Yang PG; Tian Y
Oncol Res; 2016; 23(3):129-36. PubMed ID: 26931435
[TBL] [Abstract][Full Text] [Related]
12. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.
Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K
J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438
[TBL] [Abstract][Full Text] [Related]
13. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles.
Li Y; Zhang J; Wang B; Shen Y; Ouahab A
Drug Dev Ind Pharm; 2016; 42(5):737-46. PubMed ID: 26472259
[TBL] [Abstract][Full Text] [Related]
15. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
16. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
17. 5-flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer.
Anitha A; Chennazhi KP; Nair SV; Jayakumar R
J Biomed Nanotechnol; 2012 Feb; 8(1):29-42. PubMed ID: 22515092
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy.
Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN
Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047
[TBL] [Abstract][Full Text] [Related]
19. Effect of small interfering RNA targeting hypoxia-inducible factor-1α on radiosensitivity of PC3 cell line.
Huang Y; Yu J; Yan C; Hou J; Pu J; Zhang G; Fu Z; Wang X
Urology; 2012 Mar; 79(3):744.e17-24. PubMed ID: 22196409
[TBL] [Abstract][Full Text] [Related]
20. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
